- Home
- RGS vs ANVS Comparison
RGS vs ANVS Comparison
Compare RGS & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGS
- ANVS
- Stock Information
- Founded
- RGS 1922
- ANVS 2008
- Country
- RGS United States
- ANVS United States
- Employees
- RGS 1745
- ANVS N/A
- Industry
- RGS Other Consumer Services
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- RGS Consumer Discretionary
- ANVS Health Care
- Exchange
- RGS Nasdaq
- ANVS Nasdaq
- Market Cap
- RGS 66.2M
- ANVS 53.3M
- IPO Year
- RGS 1991
- ANVS 2020
- Fundamental
- Price
- RGS $26.73
- ANVS $3.56
- Analyst Decision
- RGS
- ANVS Strong Buy
- Analyst Count
- RGS 0
- ANVS 3
- Target Price
- RGS N/A
- ANVS $13.50
- AVG Volume (30 Days)
- RGS 11.1K
- ANVS 3.2M
- Earning Date
- RGS 11-12-2025
- ANVS 11-12-2025
- Dividend Yield
- RGS N/A
- ANVS N/A
- EPS Growth
- RGS 20.05
- ANVS N/A
- EPS
- RGS 45.08
- ANVS N/A
- Revenue
- RGS $223,032,000.00
- ANVS N/A
- Revenue This Year
- RGS N/A
- ANVS N/A
- Revenue Next Year
- RGS N/A
- ANVS N/A
- P/E Ratio
- RGS $0.62
- ANVS N/A
- Revenue Growth
- RGS 13.98
- ANVS N/A
- 52 Week Low
- RGS $15.00
- ANVS $1.11
- 52 Week High
- RGS $31.50
- ANVS $7.52
- Technical
- Relative Strength Index (RSI)
- RGS 41.85
- ANVS 71.20
- Support Level
- RGS $26.00
- ANVS $2.11
- Resistance Level
- RGS $27.51
- ANVS $4.00
- Average True Range (ATR)
- RGS 1.06
- ANVS 0.42
- MACD
- RGS -0.21
- ANVS 0.19
- Stochastic Oscillator
- RGS 26.44
- ANVS 80.00
About RGS Regis Corporation
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.